M
Medicus Pharma Ltd. (MDCX)
NCM – Real Time Price. Currency in USD
0.31
-0.00 (-0.95%)
Market open: May 13, 2026, 11:59 AM EDT
Get all premium features to the best stock analysis tool
Find any stock by ticker or company name
NCM – Real Time Price. Currency in USD
0.31
-0.00 (-0.95%)
Market open: May 13, 2026, 11:59 AM EDT
Medicus Pharma Ltd., a biotech/life sciences company, focuses on developing clinical development programs of therapeutic assets in the United States. It is developing SKNJCT-003, which is in Phase 2 study for the treatment of basal cell carcinoma of the skin. The company has a strategic collaboration with the Gorlin Syndrome Alliance to access to SKINJECT in Patients with Gorlin Syndrome. The company was formerly known as Interactive Capital Partners Corporation and changed its name to Medicus Pharma Ltd. in September 2023. The company was incorporated in 2008 and is headquartered in West Conshohocken, Pennsylvania.
| Name | Position |
|---|---|
| Dr. Edward J. Brennan Jr., F.A.C.S., M.D. | Chief Scientific Officer and Head of R&D Program |
| Dr. Faisal Mehmud M.D. | Chief Medical Officer |
| Dr. Raza Bokhari M.B.A., M.D. | CEO & Executive Chairman |
| Mr. Andrew Alasdair Smith | Chief Operating Officer |
| Ms. Anna Baran-Djokovic J.D. | Senior Vice President of Investor Relations |
| Ms. Maryann Adesso | Chief of Staff & Corporate Secretary |
| Ms. Viktoria Slepeniuk | Senior Vice President of Public Relations |
| Date | Type | Document |
|---|---|---|
| 2026-05-04 | DEF 14A | formdef14a.htm |
| 2026-04-29 | 10-K/A | form10ka.htm |
| 2026-04-24 | 8-K | form8k.htm |
| 2026-04-21 | PRE 14A | formpre14a.htm |
| 2026-03-25 | POS AM | formposam.htm |
| 2026-03-06 | 8-K | form8k.htm |
| 2026-01-30 | S-3 | forms3.htm |
| 2026-01-30 | CORRESP | filename1.htm |
| 2026-01-12 | DRS | filename1.htm |
| 2025-12-10 | DRS | filename1.htm |